Evidence map›Paper›PMID 36026497›Full record

ArticlePloS one2022

Whole exome sequencing reveals novel risk genes of pituitary neuroendocrine tumors.

Raitis Peculis, Vita Rovite, Kaspars Megnis, Inga Balcere, Austra Breiksa, Jurijs Nazarovs, Janis Stukens, Ilze Konrade, Jelizaveta Sokolovska, Valdis Pirags and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Transcriptome-Derived Ligand-Receptor Interactome of Major PitNET Subgroups.Journal of neurological surgery. Part B, Skull base · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Raitis PeculisHuman Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.ORCID 0000-0003-1107-4550
Vita RoviteHuman Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Kaspars MegnisHuman Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.ORCID 0000-0002-2587-9272
Inga BalcereDepartment of Internal Medicine, Riga Stradins University, Riga, Latvia.
Austra BreiksaInstitute of Pathology, Pauls Stradins Clinical University Hospital, Riga, Latvia.
Jurijs NazarovsInstitute of Pathology, Pauls Stradins Clinical University Hospital, Riga, Latvia.
Janis StukensDepartment of Neurosurgery, Pauls Stradins Clinical University Hospital, Riga, Latvia.
Ilze KonradeHuman Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Jelizaveta SokolovskaFaculty of Medicine, University of Latvia, Riga, Latvia.
Valdis PiragsHuman Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.
Janis KlovinsHuman Genetics and Molecular Medicine, Latvian Biomedical Research and Study Centre, Riga, Latvia.ORCID 0000-0001-8362-5505
Latvian Biomedical Research and Study Centre · LVPauls Stradiņš Clinical University Hospital · LVRiga Stradiņš University · LVUniversity of Latvia · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Somatic genetic alterations in pituitary neuroendocrine tumors (PitNET) tissues have been identified in several studies, but detection of overlapping somatic PitNET candidate genes is rare. We sequenced and by employing multiple data analysis methods studied the exomes of 15 PitNET patients to improve discovery of novel factors involved in PitNET development. PitNET patients were recruited to the study before PitNET removal surgery. For each patient, two samples for DNA extraction were acquired: venous blood and PitNET tissue. Exome sequencing was performed using Illumina NexSeq 500 sequencer and data analyzed using two separate workflows and variant calling algorithms: GATK and Strelka2. A combination of two data analysis pipelines discovered 144 PitNET specific somatic variants (mean = 9.6, range 0-19 per PitNET) of which all were SNVs. Also, we detected previously known GNAS PitNET mutation and identified somatic variants in 11 genes, which have contained somatic variants in previous WES and WGS studies of PitNETs. Noteworthy, this is the third study detecting somatic variants in gene RYR1 in the exomes of PitNETs. In conclusion, we have identified two novel PitNET candidate genes (AC002519.6 and AHNAK) with recurrent somatic variants in our PitNET cohort and found 13 genes overlapping from previous PitNET studies that contain somatic variants. Our study demonstrated that the use of multiple sequencing data analysis pipelines can provide more accurate identification of somatic variants in PitNETs.

Indexed as

Neuroendocrine TumorsPituitary NeoplasmsExomeExome SequencingHigh-Throughput Nucleotide SequencingHumans

Identifiers

PMID36026497
PMCPMC9417189
OpenAlexW4293155476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.